1-10 of 10
Hubert Köppler
Close
Sort by
Journal Articles

Survival Improvement of Patients with Chronic Lymphocytic Leukemia (CLL) in Routine Care 1995 - 2017

Rudolf Weide, Prof., Stefan Feiten, Geothy Chakupurakal, MBBS, MRCPath, PhD, Vera Friesenhahn, Kristina Kleboth, Hubert Köppler, Prof., Julia Lutschkin, Jörg Thomalla, MD, Christoph van Roye, MD, Jochen Heymanns, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4823.
https://doi.org/10.1182/blood-2018-99-109862
Published: 2018
Journal Articles

Prognostic Impact of Immunohistochemistry and MRD Results in Bone Marrow after Frontline Chemoimmunotherapy of Chronic Lymphocytic Leukemia (CLL): Results of Central Laboratory Analyses of the CLL10 Trial of the German CLL Study Group (GCLLSG)

Nadine Kutsch, MD, Sebastian Böttcher, MD PhD, Sandra Robrecht, PhD, Jasmin Bahlo, PhD, Christian Maurer, MD, Elisabeth Lange, MD, Hubert Köppler, MD, Michael G Kiehl, MD, Martin Sökler, MD, Rudolf Schlag, MD, Ursula Vehling-Kaiser, MD, Georg Köchling, MD, Christoph Plöger, MD, Michael Gregor, MD, Torben Plesner, MD, Ilske Oschlies, MD, Marco Herling, MD PhD, Kirsten Fischer, MD, Hartmut Döhner, MD, Michael Kneba, MD, Clemens-Martin Wendtner, MD, Karl-Anton Kreuzer, MD, Stephan Stilgenbauer, MD PhD, Anna Maria Fink, MD, Michael Hallek, MD, Wolfram Klapper, MD, Barbara F. Eichhorst, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3021.
https://doi.org/10.1182/blood.V130.Suppl_1.3021.3021
Published: 2017
Journal Articles

Favorable Toxicity Profile and Long Term Outcome of Elderly, but Physically Fit CLL Patients (pts) Receiving First Line Bendamustine and Rituximab (BR) Frontline Chemoimmunotherapy in Comparison to Fludarabine, Cyclophosphamide, and Rituximab (FCR) in Advanced Chronic Lymphocytic Leukemia (CLL): Update Analysis of an International, Randomized Study of the German CLL Study Group (GCLLSG) (CLL10 Study)

Barbara F. Eichhorst, MD, Jasmin Bahlo, Christian Maurer, MD, Elisabeth Lange, MD, Hubert Köppler, Prof., Michael G Kiehl, MD, Martin Sökler, MD, Rudolf Schlag, Ursula Vehling-Kaiser, MD, Georg Köchling, MD, Christoph Plöger, MD, Michael Gregor, Torben Plesner, MD, Marco Herling, MD PhD, Kirsten Fischer, Hartmut Döhner, MD, Michael Kneba, Clemens Wendtner, MD, Wolfram Klapper, MD, Karl-Anton Kreuzer, Sebastian Böttcher, Stephan Stilgenbauer, Anna Maria Fink, MD, Michael Hallek
Journal: Blood
Blood (2016) 128 (22): 4382.
https://doi.org/10.1182/blood.V128.22.4382.4382
Published: 2016
Journal Articles

Survival Improvement of Patients with Chronic Lymphocytic Leukemia (CLL) in Routine Care. a Retrospective Analysis of All Patients with CLL Who Were Treated in an Oncology Group Practice in Germany Between 1995-2015

Rudolf Weide, Prof., Stefan Feiten, Geothy Chakupurakal, MBBS, MRCPath, PhD, Vera Friesenhahn, Kristina Kleboth, Julia Lutschkin, Jörg Thomalla, MD, Christoph van Roye, MD, Jochen Heymanns, MD, Hubert Köppler, Prof.
Journal: Blood
Blood (2016) 128 (22): 5961.
https://doi.org/10.1182/blood.V128.22.5961.5961
Published: 2016
Journal Articles

Treatment Reality of Patients with Immune Thrombocytopenia (ITP) in Routine Care

Rudolf Weide, MD, Stefan Feiten, Vera Friesenhahn, Jochen Heymanns, MD, Kristina Kleboth, Jörg Thomalla, MD, Christoph van Roye, MD, Hubert Köppler, Prof. Dr.
Journal: Blood
Blood (2014) 124 (21): 5009.
https://doi.org/10.1182/blood.V124.21.5009.5009
Published: 2014
Journal Articles

Frontline Chemoimmunotherapy with Fludarabine (F), Cyclophosphamide (C), and Rituximab (R) (FCR) Shows Superior Efficacy in Comparison to Bendamustine (B) and Rituximab (BR) in Previously Untreated and Physically Fit Patients (pts) with Advanced Chronic Lymphocytic Leukemia (CLL): Final Analysis of an International, Randomized Study of the German CLL Study Group (GCLLSG) (CLL10 Study)

Barbara Eichhorst, MD, Anna Maria Fink, MD, Raymonde Busch, Gabor Kovacs, MD, Christian Maurer, MD, Elisabeth Lange, MD, Hubert Köppler, Prof. Dr., Michael G Kiehl, MD, Martin Soekler, MD, Rudolf Schlag, Ursula Vehling-Kaiser, MD, Georg R.A. Köchling, MD, Christoph Plöger, MD, Michael Gregor, MD, Torben Plesner, MD, Marek Trneny, MD, Kirsten Fischer, Hartmut Döhner, MD, Michael Kneba, MD PhD, Clemens-Martin Wendtner, MD, Wolfram Klapper, MD, Karl Anton Kreuzer, Prof. Dr. MD, Stephan Stilgenbauer, MD PhD, Sebastian Böttcher, MD, Michael Hallek, MD
Journal: Blood
Blood (2014) 124 (21): 19.
https://doi.org/10.1182/blood.V124.21.19.19
Published: 2014
Journal Articles

Bendamustine + Rituximab-Combinations and R-CHOP Achieve a Major Survival Improvement Of Patients With Follicular Lymphoma In Routine Care

Rudolf Weide, Prof. Dr., Stefan Feiten, Vera Friesenhahn, Jochen Heymanns, MD, Kristina Kleboth, Jörg Thomalla, MD, Christoph van Roye, MD, Hubert Köppler, Prof. Dr.
Journal: Blood
Blood (2013) 122 (21): 5584.
https://doi.org/10.1182/blood.V122.21.5584.5584
Published: 2013
Journal Articles

Bendamustine and Rituximab Achieve a Major Survival Improvement Of Patients With Morbus Waldenström In Routine Care

Rudolf Weide, Stefan Feiten, Vera Friesenhahn, Jochen Heymanns, MD, Kristina Kleboth, Jörg Thomalla, MD, Christoph van Roye, MD, Hubert Köppler
Journal: Blood
Blood (2013) 122 (21): 5611.
https://doi.org/10.1182/blood.V122.21.5611.5611
Published: 2013
Journal Articles

Sequential Treatment With Bendamustine, Rituximab, Chlorambucil and Fludarabine Leads To a Major Survival Improvement Of Patients With Chronic Lymphocytic Leukemia (CLL) In Routine Care

Rudolf Weide, Stefan Feiten, Vera Friesenhahn, Jochen Heymanns, MD, Kristina Kleboth, Jörg Thomalla, MD, Christoph van Roye, MD, Hubert Köppler
Journal: Blood
Blood (2013) 122 (21): 5613.
https://doi.org/10.1182/blood.V122.21.5613.5613
Published: 2013
Journal Articles

Chemoimmunotherapy With Fludarabine (F), Cyclophosphamide (C), and Rituximab (R) (FCR) Versus Bendamustine and Rituximab (BR) In Previously Untreated and Physically Fit Patients (pts) With Advanced Chronic Lymphocytic Leukemia (CLL): Results Of a Planned Interim Analysis Of The CLL10 Trial, An International, Randomized Study Of The German CLL Study Group (GCLLSG)

Barbara Eichhorst, MD, Anna-Maria Fink, MD, Raymonde Busch, PhD, Elisabeth Lange, MD, Hubert Köppler, Michael Kiehl, MD, Martin Sökler, MD, Rudolf Schlag, MD, Ursula Vehling-Kaiser, MD, Georg Köchling, MD, Christoph Plöger, MD, Michael Gregor, MD, Torben Plesner, MD, Marek Trneny, MD, Ph.D., Kirsten Fischer, MD, Hartmut Döhner, MD, Michael Kneba, MD, Clemens Wendtner, MD, Wolfram Klapper, Karl-Anton Kreuzer, Stephan Stilgenbauer, MD, Sebastian Böttcher, MD, Michael Hallek, MD
Journal: Blood
Blood (2013) 122 (21): 526.
https://doi.org/10.1182/blood.V122.21.526.526
Published: 2013